53 studies found for:    Open Studies | "Vitamin K"
Show Display Options
Rank Status Study
21 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
22 Not yet recruiting Tecarfarin Anti-Coagulation Trial (TACT)
Conditions: Thromboembolism;   Thrombosis
Interventions: Drug: Warfarin;   Drug: tecarfarin
23 Recruiting Novel Oral Anticoagulants in Stroke Patients
Conditions: Ischemic Stroke,;   Intracranial Hemorrhage,
Intervention:
24 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
25 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
26 Recruiting Anti Vitamin K Therapeutic Education
Condition: Cardio-vascular Diseases
Intervention: Other: therapeutic education program
27 Recruiting Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
Conditions: Atrial Fibrillation or Pulmonary Embolism;   Need of Long Term Oral Anticoagulation Therapy (OAT);   Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
Intervention: Drug: Rivaroxaban or Marcumar
28 Recruiting PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma
Conditions: Coagulation; Intravascular;   Craniocerebral Trauma;   Haemorrhage
Intervention: Procedure: Reversion
29 Recruiting Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects
Conditions: Acute Major Bleeding;   Reversal of Coagulopathy
Intervention: Biological: BE1116 (Prothrombin Complex Concentrate)
30 Recruiting Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
Conditions: Permanent Atrial Fibrillation;   Venous Thrombosis;   Pulmonary Embolism;   Anticoagulating Treatment on a Duration at Least 12-month-old Superior
Interventions: Drug: Rivaroxaban;   Drug: Fluindione;   Drug: Warfarin
31 Recruiting Optimal Duration of Anticoagulation in Deep Venous Thrombosis
Conditions: Deep Venous Thrombosis of the Lower Extremities;   Symptomatic Recurrent Venous Thromboembolism
Intervention: Drug: Sodium warfarin
32 Recruiting Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
33 Recruiting EINSTEIN Junior Phase III: Oral Rivaroxaban in Children With Venous Thrombosis
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of Care
34 Recruiting Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
Condition: Venous Thromboembolism
Interventions: Drug: dabigatran etexilate;   Drug: standard of care
35 Recruiting Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
Condition: Prosthetic Valve Thrombosis
Intervention: Drug: Warfarin
36 Recruiting FFP Versus PCC in Intracranial Hemorrhage
Conditions: Intracranial Hemorrhage, Traumatic;   Intracranial Hemorrhage, Spontaneous
Interventions: Drug: Four Factor Prothrombin Complex Concentrate;   Biological: Fresh Frozen Plasma
37 Recruiting Atrial Fibrillation in Turkey: Epidemiologic Registry-2
Condition: Atrial Fibrillation
Intervention:
38 Not yet recruiting RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial
Condition: Valvular Heart Disease
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
39 Recruiting Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.
Condition: Acute Gastrointestinal Bleeding
Interventions: Drug: warfarin;   Drug: Bemiparina
40 Unknown  A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI
Condition: Rash Due to Epidermal Growth Factor Receptor Inhibitors
Interventions: Drug: RECONVAL CREAM;   Drug: PLACEBO

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-53) Show next page of results    Last Page
Indicates status has not been verified in more than two years